<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK548684" /><meta name="ncbi_domain" content="livertox" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK548684/" /><meta name="ncbi_pagename" content="Celandine - LiverTox - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Celandine - LiverTox - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]" /><meta name="citation_title" content="Celandine" /><meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="citation_date" content="2017/01/22" /><meta name="citation_pmid" content="31643995" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK548684/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Celandine" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="DC.Date" content="2017/01/22" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK548684/" /><meta name="description" content="Greater celandine is a botanical extract derived from a plant of the Poppy family that is typically used for the treatment of gastrointestinal disorders and dyspepsia. Celandine has been linked to several instances of clinically apparent liver injury." /><meta name="og:title" content="Celandine" /><meta name="og:type" content="book" /><meta name="og:description" content="Greater celandine is a botanical extract derived from a plant of the Poppy family that is typically used for the treatment of gastrointestinal disorders and dyspepsia. Celandine has been linked to several instances of clinically apparent liver injury." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK548684/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/livertox/Celandine/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK548684/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C89D204676ED10000000000FA004B.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All Drug Records" href="/books/n/livertox/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" alt="Cover of LiverTox" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK548684_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK548684_dtls__"><div>Bethesda (MD): <a href="https://www.niddk.nih.gov/" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">National Institute of Diabetes and Digestive and Kidney Diseases</a>; 2012-.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/livertox/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search this book" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search this book" submit="false" style="padding: 0.1em 0.4em;" /></div></form></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Ceftriaxone/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Celecoxib/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK548684_"><span class="title" itemprop="name">Celandine</span></h1><p class="small">Last Update: <span itemprop="dateModified">January 22, 2017</span>.</p></div><div class="body-content whole_rhythm" itemprop="text"><div id="Celandine.OVERVIEW"><h2 id="_Celandine_OVERVIEW_">OVERVIEW</h2><div id="Celandine.Introduction"><h3>Introduction</h3><p>Greater celandine is a botanical extract derived from a plant of the Poppy family that is typically used for the treatment of gastrointestinal disorders and dyspepsia. Celandine has been linked to several instances of clinically apparent liver injury.</p></div><div id="Celandine.Background"><h3>Background</h3><p>Greater celandine (Chelidonium majus) is a plant of the Poppy family (Papaveraceae) which grows wild in Asia and Europe and has been introduced widely in the United States. Leaf extracts may contain up to 20 alkaloids, including benzophenanthridines, protoberberines and hydroxycinnamic acid derivatives. For centuries, celandine has been used to treat gastrointestinal complaints, dyspepsia and gallbladder disease. The chemical compound responsible for the antispasmotic activity of celandine is unknown. Celandine also acts as a mild sedative and it has been used to treat asthma, bronchitis and whooping cough. In recent years, celandine extracts have been used largely as therapy for dyspepsia and gallbladder disease, but it has also been claimed to be beneficial for skin conditions, asthma and bronchitis and as a weight loss agent. No human studies have been done that substantiate the benefits of celandine in these conditions or to define its safety, tolerability and adverse effects.</p></div><div id="Celandine.Hepatotoxicity"><h3>Hepatotoxicity</h3><p>Over a dozen publications, largely from Europe, have described clinically apparent acute liver injury attributable to greater celandine (Chelidonium majus). Liver injury typically arises after 1 to 6 months, with jaundice and moderate to marked elevations in serum aminotransferase levels. The pattern of injury is usually hepatocellular and the clinical presentation and liver histology resemble acute viral hepatitis. Immunoallergic features are uncommon, but autoantibodies may be present in low to moderate levels in many cases. The clinical syndrome, however, rarely resembles autoimmune hepatitis and usually resolves rapidly once the botanical is discontinued and without need of corticosteroid therapy.</p></div><div id="Celandine.Mechanism_of_Injury"><h3>Mechanism of Injury</h3><p>Greater celandine extracts have many components, but none of them has been shown to be specifically hepatotoxic. The rare cases of liver injury due to celandine have had idiosyncratic features.</p></div><div id="Celandine.Outcome_and_Management"><h3>Outcome and Management</h3><p><a class="def" href="/books/n/livertox/glossary/def-item/glossary.hepatotoxicity/">Hepatotoxicity</a> from celandine is rare; some cases have been severe, but fatal cases and acute liver failure leading to liver transplantation has not been described. Recurrence with reexposure has been documented in several cases and rechallenge should be avoided.</p><p>Drug Class: <a href="/books/n/livertox/HerbalDietarySuppl/">Herbal and Dietary Supplements</a></p></div></div><div id="Celandine.CASE_REPORT"><h2 id="_Celandine_CASE_REPORT_">CASE REPORT</h2><div id="Celandine.Case_1._Acute_hepatitis_due_to"><h3>Case 1. Acute hepatitis due to greater celandine.</h3><p>[Modified from: Crijns AP, de Smet PA, van den Heuvel M, Schot BW, Haagsma EB. [Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus)]. Ned Tijdschr Geneeskd 2002; 146: 124-8. Dutch. <a href="https://www.ncbi.nlm.nih.gov/pubmed/11826672" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>]</p><p>A 42 year old woman developed fever, muscle aches, headaches, fatigue and abdominal discomfort 2 weeks after starting an oral herbal preparation containing greater celandine (Chelidonium majus) for a skin condition. The fever resolved in two weeks, but she continued to have generalized fatigue and then developed dark urine, light colored stools and jaundice. She sought medical care and the herbal preparation was discontinued. She had no history of liver disease, did not drink alcohol and denied risk factors for viral hepatitis. She was taking no other medications. On examination, she was jaundiced but had no signs of chronic liver disease. Laboratory results showed normal blood counts, but hyperbilirubinemia (~8.1 mg/dL) and marked elevations in serum <a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> (~2900 U/L). Because of worsening jaundice, she was transferred to a referral hospital (Table). Tests for hepatitis A, B and C were negative as were autoantibodies. <a class="def" href="/books/n/livertox/glossary/def-item/glossary.immunoglobulin/">Immunoglobulin</a> levels were normal. Liver ultrasound showed no evidence of biliary obstruction. A liver biopsy showed lymphocytic infiltrates and spotty necrosis with cell drop out in central areas with cholestasis. Thereafter, she improved symptomatically and in follow up her liver tests returned to the normal range.</p><div id="Celandine.Key_Points"><h4>Key Points</h4><div id="Celandine.T1" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548684/table/Celandine.T1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Celandine.T1_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Medication:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Greater celandine (Chelidonium majus)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Pattern:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Hepatocellular (R=11.7, at week 9)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Severity:</td><td rowspan="1" colspan="1" style="vertical-align:top;">3+ (jaundice, hospitalization)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.latency/">Latency</a>:</td><td rowspan="1" colspan="1" style="vertical-align:top;">2 weeks to symptoms, 5 weeks to jaundice</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Recovery:</td><td rowspan="1" colspan="1" style="vertical-align:top;">8 weeks</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Other medications:</td><td rowspan="1" colspan="1" style="vertical-align:top;">None</td></tr></tbody></table></div></div></div><div id="Celandine.Laboratory_Values"><h4>Laboratory Values</h4><div id="Celandine.T2" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548684/table/Celandine.T2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Celandine.T2_lrgtbl__"><table><thead><tr><th id="hd_h_Celandine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Time After Starting</th><th id="hd_h_Celandine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Time After Stopping</th><th id="hd_h_Celandine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> (U/L)*</th><th id="hd_h_Celandine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Alk P (U/L)</th><th id="hd_h_Celandine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.bilirubin/">Bilirubin</a> (mg/dL)*</th><th id="hd_h_Celandine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Other</th></tr></thead><tbody><tr><td headers="hd_h_Celandine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Celandine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Celandine.T2_1_1_1_3 hd_h_Celandine.T2_1_1_1_4 hd_h_Celandine.T2_1_1_1_5 hd_h_Celandine.T2_1_1_1_6" colspan="4" rowspan="1" style="vertical-align:top;">Started celandine for skin disorder</td></tr><tr><td headers="hd_h_Celandine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">5 weeks</td><td headers="hd_h_Celandine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Celandine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">3200</td><td headers="hd_h_Celandine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Celandine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">8.2</td><td headers="hd_h_Celandine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Celandine stopped</td></tr><tr><td headers="hd_h_Celandine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">8 weeks</td><td headers="hd_h_Celandine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">3 weeks</td><td headers="hd_h_Celandine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">2900</td><td headers="hd_h_Celandine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Celandine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">10.8</td><td headers="hd_h_Celandine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Hospital transfer</td></tr><tr><td headers="hd_h_Celandine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">9 weeks</td><td headers="hd_h_Celandine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">4 weeks</td><td headers="hd_h_Celandine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">1490</td><td headers="hd_h_Celandine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">265</td><td headers="hd_h_Celandine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">11.7</td><td headers="hd_h_Celandine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Celandine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">10 weeks</td><td headers="hd_h_Celandine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">5 weeks</td><td headers="hd_h_Celandine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">700</td><td headers="hd_h_Celandine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Celandine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">7.0</td><td headers="hd_h_Celandine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Liver biopsy</td></tr><tr><td headers="hd_h_Celandine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">13 weeks</td><td headers="hd_h_Celandine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">8 weeks</td><td headers="hd_h_Celandine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">29</td><td headers="hd_h_Celandine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">115</td><td headers="hd_h_Celandine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.3</td><td headers="hd_h_Celandine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Celandine.T2_1_1_1_1 hd_h_Celandine.T2_1_1_1_2" colspan="2" rowspan="1" style="vertical-align:top;"><b>Normal Values</b></td><td headers="hd_h_Celandine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;30</b></td><td headers="hd_h_Celandine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;120</b></td><td headers="hd_h_Celandine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;1.2</b></td><td headers="hd_h_Celandine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div></div><p>* Values estimated from Figure 2 (laboratory parameters are mislabeled).</p></div><div id="Celandine.Comment"><h4>Comment</h4><p>The case history is typical of greater celandine hepatotoxicity. Other causes of acute liver injury were appropriately excluded. The onset of injury within 2 to 5 weeks of starting and resolution within 8 weeks of stopping the herbal product provides good evidence that the liver injury was caused by it. <a class="def" href="/books/n/livertox/glossary/def-item/glossary.rechallenge/">Rechallenge</a> is not necessary for the diagnosis; other cases of celandine hepatotoxicity have demonstrated recurrence upon rechallenge. Greater celandine was used widely in Europe but rarely in the United States, so virtually all published cases are from Europe, including Germany, Spain, Italy, Belgium and the Netherlands.</p></div></div></div><div id="Celandine.PRODUCT_INFORMATION"><h2 id="_Celandine_PRODUCT_INFORMATION_">PRODUCT INFORMATION</h2><div id="Celandine.BPI" class="box"><p><b>REPRESENTATIVE TRADE NAMES</b></p><p>Greater Celandine &#x02013; Generic</p><p><b>DRUG CLASS</b></p><p>Herbal and <a class="def" href="/books/n/livertox/glossary/def-item/glossary.dietary-supplements/">Dietary Supplements</a></p></div></div><div id="Celandine.CHEMICAL_FORMULA_AND_STRUCTURE"><h2 id="_Celandine_CHEMICAL_FORMULA_AND_STRUCTURE_">CHEMICAL FORMULA AND STRUCTURE</h2><div id="Celandine.T3" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548684/table/Celandine.T3/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Celandine.T3_lrgtbl__"><table><thead><tr><th id="hd_h_Celandine.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">DRUG</th><th id="hd_h_Celandine.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">CAS REGISTRY NUMBER</th><th id="hd_h_Celandine.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">MOLECULAR FORMULA</th><th id="hd_h_Celandine.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">STRUCTURE</th></tr></thead><tbody><tr><td headers="hd_h_Celandine.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Greater Celandine</td><td headers="hd_h_Celandine.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">ID: FL96000000</td><td headers="hd_h_Celandine.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Herbal mixture</td><td headers="hd_h_Celandine.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Not applicable</td></tr></tbody></table></div></div></div><div id="Celandine.ANNOTATED_BIBLIOGRAPHY"><h2 id="_Celandine_ANNOTATED_BIBLIOGRAPHY_">ANNOTATED BIBLIOGRAPHY</h2><p>References updated: 22 January 2017</p><ul class="first-line-outdent"><li><div class="bk_ref" id="Celandine.R1">Zimmerman HJ. Unconventional drugs. Miscellaneous drugs and diagnostic chemicals. In, Zimmerman, HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott,1999: pp. 731-4.<div><i>(Expert review of hepatotoxicity published in 1999; hepatotoxicity of herbals is discussed but not greater celandine specifically).</i></div></div></li><li><div class="bk_ref" id="Celandine.R2">Seeff L, Stickel F, Navarro VJ. Hepatotoxicity of herbals and dietary supplements. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd ed. Amsterdam: Elsevier, 2013, pp. 631-58. <em>(Review of hepatotoxicity of herbal and dietary supplements [HDS] mentions</em>.<div><i>that greater celandine has been used in Europe to treat dyspepsia and gallstones and that multiple cases of acute hepatitis including a case series of 10 instances attributable to celandine have been published).</i></div></div></li><li><div class="bk_ref" id="Celandine.R3">Celandine. In, PDR for Herbal Medicines. 4th ed. Montvale, New Jersey: Thomson Healthcare Inc. 2007: pp. 180-1.<div><i>(Compilation of short monographs on herbal medications and dietary supplements).</i></div></div></li><li><div class="bk_ref" id="Celandine.R4">Pinto Garc&#x000ed;a V, Vicente PR, Barez A, Soto I, Candas MA, Coma A. [Hemolytic anemia induced by Chelidonium majus. Clinical case]. Sangre(Barc) 1990; 35: 401-3. Spanish.  [<a href="/pubmed/2291149" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2291149</span></a>]<div><i>(72 year old woman developed hemolytic anemia and renal dysfunction with hepatic involvement after taking greater celandine [bilirubin 1.7 mg/dL, ALT 538 U/L], resolving rapidly upon stopping).</i></div></div></li><li><div class="bk_ref" id="Celandine.R5">De Smet PA, Van den Eertwegh AJ, Lesterhuis W, Stricker BH. Hepatotoxicity associated with herbal tablets. BMJ 1996; 313: 92.  [<a href="/pmc/articles/PMC2351519/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2351519</span></a>] [<a href="/pubmed/8688761" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8688761</span></a>]<div><i>(69 year old woman developed jaundice six weeks after starting herbal tablets &#x0201c;Venencapsan&#x0201d; prepared locally from horsechestnut leaf, milfoil, celandine, sweet clover, milk thistle and dandelion root, recurring on reexposure [bilirubin 1.6 and 4.7 mg/dL, ALT 244 and 1004 U/L, Alk P 229 and 250 U/L] and resolving rapidly on stopping).</i></div></div></li><li><div class="bk_ref" id="Celandine.R6">Strahl S, Ehret V, Dahm HH, Maier KP. [Necrotizing hepatitis after taking herbal remedies]. Dtsch Med Wochenschr 1998; 123: 1410-4. German.  [<a href="/pubmed/9856112" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9856112</span></a>]<div><i>(42 year old woman developed repeated bouts of jaundice 6 months and then 6 weeks after staring celandine [bilirubin 3.6 and 4.4 mg/dL, ALT 427 and 389 U/L, GGT 87 U/L, Alk P 221 U/L], resolving within 2 months of stopping each time).</i></div></div></li><li><div class="bk_ref" id="Celandine.R7">Greving I, Meister V, Monnerjahn C, Mueller KM. Chelidonium majus: a rare reason for severe hepatotoxic reaction. Pharmacoepidemiol Drug Saf 1998; 7: S66-S9.  [<a href="/pubmed/15073964" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15073964</span></a>]<div><i>(Two cases: a 28 year old woman developed jaundice and itching 5 months after starting greater celandine [bilirubin 16.4 mg/dL, ALT 432 U/L], resolving in 2 months; 35 year old woman developed jaundice and abdominal pain 4 months after starting celandine [bilirubin 16.1 mg/dL, ALT 654 U/L], resolving within a few months of stopping).</i></div></div></li><li><div class="bk_ref" id="Celandine.R8">Benninger J, Schneider HT, Schuppan D, Kirchner T, Hahn EG. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology 1999; 117: 1234-7.  [<a href="/pubmed/10535888" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10535888</span></a>]<div><i>(Report of 10 cases of hepatitis attributed to greater celandine; all women, ages 37 to 67 years, taking celandine for digestive disorders or eczema for 1 to 9 months, presented with symptoms [bilirubin normal in 5 and 4.5-21.7 mg/dL in the rest, ALT 123-1338 U/L, Alk P 65-451 U/L], resolving within 2-6 months in all; one patient had recurrence on restarting celandine).</i></div></div></li><li><div class="bk_ref" id="Celandine.R9">Chitturi S, Farrell GC. Drug-induced cholestasis. Semin Gastrointest Dis 2001; 12: 113-24.  [<a href="/pubmed/11352118" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11352118</span></a>]<div><i>(Review of hepatotoxicity manifested by prominent cholestatic features; discusses greater celandine, although usual presentation is with an acute hepatitis-like syndrome).</i></div></div></li><li><div class="bk_ref" id="Celandine.R10">Stickel F, Seitz HK, Hahn EG, Schuppan D. [Liver toxicity of drugs of plant origin]. Z Gastroenterol 2001; 39: 225-32, 234-7. German.  [<a href="/pubmed/11324140" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11324140</span></a>]<div><i>(Review of hepatotoxicity of botanicals including pyrrolizidine alkaloids, germander, greater celandine, chaparral, Chinese herbs and pennyroyal).</i></div></div></li><li><div class="bk_ref" id="Celandine.R11">De Smet PA. Safety concerns about kava not unique. Lancet 2002: 1336.  [<a href="/pubmed/12414243" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12414243</span></a>]<div><i>(Letter indicating that greater celandine like kava has been linked to several cases of severe liver injury and a warning label was added in Germany).</i></div></div></li><li><div class="bk_ref" id="Celandine.R12">Crijns AP, de Smet PA, van den Heuvel M, Schot BW, Haagsma EB. [Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus)]. Ned Tijdschr Geneeskd 2002; 146: 124-8. Dutch.  [<a href="/pubmed/11826672" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11826672</span></a>]<div><i>(42 year old woman developed fever and abdominal pain 2 weeks after starting greater celandine, followed by fatigue and jaundice at 5 weeks [bilirubin 8.1 rising to 11.7 mg/dL, ALT 2900 U/L, Alk P 265 U/L], worsening for a few weeks and then resolving 2 months after stopping: Case 1).</i></div></div></li><li><div class="bk_ref" id="Celandine.R13">van Noordwijk J. ["Dosis solum facit venenum" also for herbal products]. Ned Tijdschr Geneeskd 2002; 146: 100-2. Dutch.  [<a href="/pubmed/11826667" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11826667</span></a>]<div><i>(Editorial in response to Crijns [2002] &#x0201c;Search first for a poison, or for a plant product&#x0201d;; plant products are not necessarily safer than prescription medications).</i></div></div></li><li><div class="bk_ref" id="Celandine.R14">Stedman C. Herbal hepatotoxicity. Semin Liver Dis 2002; 22: 195-206.  [<a href="/pubmed/12016550" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12016550</span></a>]<div><i>(Review and description of patterns of liver injury due to herbal medications, including discussion of potential risk factors, and herb-drug interactions; greater celandine has been implicated in 10 cases of acute hepatitis with onset within 3 months in most and resolution in all, generally within 2 to 6 months of stopping).</i></div></div></li><li><div class="bk_ref" id="Celandine.R15">Stickel F, P&#x000f6;schl G, Seitz HK, Waldherr R, Hahn EG, Schuppan D. Acute hepatitis induced by Greater Celandine (Chelidonium majus). Scand J Gastroenterol 2003; 38: 565-8.  [<a href="/pubmed/12795472" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12795472</span></a>]<div><i>(2 cases: 39 year old woman developed jaundice 4 weeks after starting celandine [bilirubin 7.1 rising to 13.5 mg/dL, ALT 912 U/L, Alk P 116 U/L], with recurrence on restarting and resolution in 7 weeks on stopping; 69 year old man developed jaundice 6 weeks after starting celandine [bilirubin 9.1 mg/dL, ALT 881 U/L, Alk P 312 U/L], with resolution on stopping).</i></div></div></li><li><div class="bk_ref" id="Celandine.R16">Schiano TD. Hepatotoxicity and complementary and alternative medicines. Clin Liver Dis 2003; 7: 453-73.  [<a href="/pubmed/12879994" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12879994</span></a>]<div><i>(Comprehensive review of herbal associated hepatotoxicity, including common patterns of presentation and a specific discussion of greater celandine).</i></div></div></li><li><div class="bk_ref" id="Celandine.R17">Pittler MH, Ernest E. Systematic review: hepatotoxic events associated with herbal medicinal products. Aliment Pharmacol Ther 2003; 18: 451-71.  [<a href="/pubmed/12950418" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12950418</span></a>]<div><i>(Systematic review of published cases of hepatotoxicity due to herbal medications listing 52 case reports or case series, most common agents being greater celandine [3], chaparral [3], germander [8], Jin Bu Huan [3], kava [1], Ma Huang [3], pennyroyal oil [1], skullcap [2], Chinese herbs [9], valerian [1]).</i></div></div></li><li><div class="bk_ref" id="Celandine.R18">Estes JD, Stolpman D, Olyaei A, Corless CL, Ham JM, Schwartz JM, Orloff SL. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 2003; 138: 852-8.  [<a href="/pubmed/12912743" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12912743</span></a>]<div><i>(Among 20 patients undergoing liver transplantation for acute liver failure during 2001-2, 10 were potentially caused by herbals: none were attributed to celandine).</i></div></div></li><li><div class="bk_ref" id="Celandine.R19">Pak E, Esrason KT, Wu VH. Hepatotoxicity of herbal remedies: an emerging dilemma. Prog Transplant 2004; 15: 91-6.  [<a href="/pubmed/15264453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15264453</span></a>]<div><i>(Review of hepatotoxicity of herbal medications stressing the recent rise in numbers of cases, with literature review of cases due to greater celandine).</i></div></div></li><li><div class="bk_ref" id="Celandine.R20">Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug-induced liver injury in the United States. Liver Transpl 2004; 10: 1018-23.  [<a href="/pubmed/15390328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15390328</span></a>]<div><i>(Among ~50,000 liver transplants reported to UNOS between 1990 and 2002, 270 [0.5%] were done for drug induced acute liver failure, including 7 [5%] for herbal medications, but celandine not mentioned as a cause).</i></div></div></li><li><div class="bk_ref" id="Celandine.R21">Rifai K, Flemming P, Manns MP, Trautwein C. [Severe drug hepatitis caused by Chelidonium]. Internist (Berl) 2006; 47: 749-51. German.  [<a href="/pubmed/16645871" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16645871</span></a>]<div><i>(58 year old man developed jaundice and pruritus 3 weeks after starting greater celandine [bilirubin 9.6 mg/dL, ALT 903 U/L], resolving within 4 weeks of stopping).</i></div></div></li><li><div class="bk_ref" id="Celandine.R22">Seeff LB. Herbal hepatotoxicity. Clin Liver Dis 2007; 11: 577-96.  [<a href="/pubmed/17723921" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17723921</span></a>]<div><i>(Review of herbal induced hepatotoxicity, with a review of the 13 cases of acute liver injury attributed to greater celandine in the literature).</i></div></div></li><li><div class="bk_ref" id="Celandine.R23">Hardeman E, Van Overbeke L, Ilegems S, Ferrante M. Acute hepatitis induced by greater celandine (Chelidonium majus). Acta Gastroenterol Belg 2008; 71: 281-2.  [<a href="/pubmed/18720945" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18720945</span></a>]<div><i>(58 year old woman developed jaundice 3 weeks after starting greater celandine [bilirubin 19.9 rising to 27 mg/dL, ALT 1566 U/L, Alk P 316 U/L], resolving rapidly upon stopping; enlarged lymph nodes in porta hepatis and ascites; biopsy showing reactive change, resolving with stopping celandine).</i></div></div></li><li><div class="bk_ref" id="Celandine.R24">Conti E, De Checchi G, Mencarelli R, Pinato S, Rovere P. Lycopodium similiaplex-induced acute hepatitis: a case report. Eur J Gastroenterol Hepatol 2008; 20: 469-71.  [<a href="/pubmed/18403950" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18403950</span></a>]<div><i>(46 year old woman developed nausea and fatigue 8 weeks after starting L similiaplex solution [L serratum and Chelidonium majus] for insomnia [bilirubin 3.2 mg/dL, ALT 2364 U/L, Alk P 255 U/L], with resolution in 2 months of stopping).</i></div></div></li><li><div class="bk_ref" id="Celandine.R25">Garc&#x000ed;a-Cort&#x000e9;s M, Borraz Y, Lucena MI, Pel&#x000e1;ez G, Salmer&#x000f3;n J, Diago M, Mart&#x000ed;nez-Sierra MC, et al. [Liver injury induced by &#x0201c;natural remedies&#x0201d;: an analysis of cases submitted to the Spanish Liver Toxicity Registry]. Rev Esp Enferm Dig 2008; 100: 688-95. Spanish.  [<a href="/pubmed/19159172" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19159172</span></a>]<div><i>(Among 521 cases of drug induced liver injury submitted to Spanish registry, 13 [2%] were due to herbals, but none were attributed to greater celandine).</i></div></div></li><li><div class="bk_ref" id="Celandine.R26">Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J; Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135: 1924-34.  [<a href="/pmc/articles/PMC3654244/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3654244</span></a>] [<a href="/pubmed/18955056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18955056</span></a>]<div><i>(Among 300 cases of drug induced liver disease in the US collected between 2004 and 2008, 9% of cases were attributed to herbal medications, but none were attributed to greater celandine).</i></div></div></li><li><div class="bk_ref" id="Celandine.R27">Tarantino G, Pezzullo MG, Dario di Minno MN, Milone F, Pezzullo LS, Milone M, Capone D. Drug-induced liver injury due to "natural products" used for weight loss: a case report. World J Gastroenterol 2009; 15: 2414-7.  [<a href="/pmc/articles/PMC2684613/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2684613</span></a>] [<a href="/pubmed/19452589" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19452589</span></a>]<div><i>(22 year old woman developed jaundice, pruritus, fever and abdominal pain [bilirubin 7.5 g/dL, ALT 1686 U/L, Alk P 1229 U/L, eosinophils 7%], responding only partially to cholecystectomy and extraction of stones from the common bile duct, whereupon she was found to have been taking greater celandine and Lycopodium serratum).</i></div></div></li><li><div class="bk_ref" id="Celandine.R28">Moro PA, Cassetti F, Giugliano G, Falce MT, Mazzanti G, Menniti-Ippolito F, Raschetti R, Santuccio C. Hepatitis from Greater celandine(Chelidonium majus L.): review of literature and report of a new case. J Ethnopharmacol 2009; 124: 328-32.  [<a href="/pubmed/19397968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19397968</span></a>]<div><i>(Case report and review of 16 cases in the literature; 65 year old man developed jaundice one month after starting daily ingestion of tea made from greater celandine extract [Chelidonium majus] [bilirubin 6.4 mg/dL, ALT 4765 U/L], with resolution within 2 months of stopping).</i></div></div></li><li><div class="bk_ref" id="Celandine.R29">Navarro VJ. Herbal and dietary supplement hepatotoxicity. Semin Liver Dis 2009; 29: 373-82.  [<a href="/pubmed/19826971" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19826971</span></a>]<div><i>(Overview of the regulatory environment, clinical patterns, and future directions in research with HDS; greater celandine is not discussed).</i></div></div></li><li><div class="bk_ref" id="Celandine.R30">Teschke R, Glass X, Schulze J. Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): causality assessment of 22 spontaneous reports. Regul Toxicol Pharmacol 2011; 61: 282-91.  [<a href="/pubmed/21893153" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21893153</span></a>]<div><i>(Analysis of 22 cases of liver injury attributed to greater celandine reported to the German Registry using RUCAM found only 8 to be probable: 3 men and 5 women, ages 32 to 66 years, with onset after 28 to 42 [mean = 36] days [bilirubin elevated in 7, ALT 420-2928 U/L, Alk P 256-408 U/L], all recovered).</i></div></div></li><li><div class="bk_ref" id="Celandine.R31">Teschke R, Frenzel C, Glass X, Schulze J, Eickhoff A. Greater Celandine hepatotoxicity: a clinical review. Ann Hepatol 2012;11:838-48.  [<a href="/pubmed/23109446" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23109446</span></a>]<div><i>(Analysis of clinical features of 16 cases of hepatotoxicity attributed to greater celandine from the European literature; 6 men and 10 women, ages 32 to 69 years, onset after 3 weeks to 4.5 months, usually with a hepatocellular pattern of injury and resolving with stopping in all).</i></div></div></li><li><div class="bk_ref" id="Celandine.R32">Teschke R, Glass X, Schulze J, Eickhoff A. Suspected Greater Celandine hepatotoxicity: liver-specific causality evaluation of published case reports from Europe. Eur J Gastroenterol Hepatol 2012; 24: 270-80.  [<a href="/pubmed/22189691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22189691</span></a>]<div><i>(Among 21 published case reports of liver injury attributed to celandine, only 8 were scored as probable by the RUCAM system: 3 men and 5 women, ages 37 to 68 years, onset in 3-12 weeks [ALT 152-4765 U/L, Alk P 221-516 U/L], resolving in 1 to 5 months of stopping).</i></div></div></li><li><div class="bk_ref" id="Celandine.R33">Teschke R, Wolff A, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: a tabular compilation of reported cases. Liver Int 2012; 32: 1543-56.  [<a href="/pubmed/22928722" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22928722</span></a>]<div><i> (A systematic compilation of all publications on the hepatotoxicity of specific herbals identified 185 publications on 60 different herbs, herbal drugs and supplements including 15 publications on greater celandine).</i></div></div></li><li><div class="bk_ref" id="Celandine.R34">Bunchorntavakul C, Reddy KR. Review article: herbal and dietary supplement hepatotoxicity. Aliment Pharmacol Ther 2013; 37: 3-17.  [<a href="/pubmed/23121117" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23121117</span></a>]<div><i>(Systematic review of literature on HDS associated liver injury discusses the clinically apparent hepatotoxicity attributed to greater celandine, reported largely from Europe).</i></div></div></li><li><div class="bk_ref" id="Celandine.R35">Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C. Herbal hepatotoxicity: suspected cases assessed for alternative causes. Eur J Gastroenterol Hepatol 2013; 25: 1093-8.  [<a href="/pubmed/23510966" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23510966</span></a>]<div><i>(Review of the literature of case series of suspected HDS related liver injury found evidence of other explanations for the liver injury in 19 of 23 publications involving 278 of 573 patients [49%], including 28 of 66 cases [42%] attributed to greater celandine, and that these other diagnoses weakened the causality assessment in most instances).</i></div></div></li><li><div class="bk_ref" id="Celandine.R36">Teschke R, Genthner A, Wolff A, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: Analysis of cases with initially reported positive re-exposure tests. Dig Liver Dis 2014; 46: 264-9.  [<a href="/pubmed/24315480" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24315480</span></a>]<div><i> (Reanalysis of 34 published cases of liver injury due to herbal medications in which there was a reported positive rechallenge, finding only 21 [62%] fulfilled the criteria of a positive rechallenge using RUCAM, the others having inconsistent [18%] or incomplete data [21%]; among 3 cases attributed to greater celandine, 1 rechallenge was considered negative and 1 uninterpretable).</i></div></div></li><li><div class="bk_ref" id="Celandine.R37">Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, et al.; United States Drug Induced Liver Injury Network. Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study. Gastroenterology 2015; 148: 1340-1352.  [<a href="/pmc/articles/PMC4446235/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4446235</span></a>] [<a href="/pubmed/25754159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25754159</span></a>]<div><i>(Among 899 cases of drug induced liver injury enrolled in a US prospective study between 2004 and 2013, 145 [16%] were attributed to herbal and dietary supplements, but none to greater celandine).</i></div></div></li><li><div class="bk_ref" id="Celandine.R38">Frenzel C, Teschke R. Herbal hepatotoxicity: clinical characteristics and listing compilation. Int J Mol Sci 2016; 17. pii: E588.  [<a href="/pmc/articles/PMC4881436/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4881436</span></a>] [<a href="/pubmed/27128912" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27128912</span></a>]<div><i>(Review of the challenges in the diagnosis of hepatotoxicity due to herbal products including problems of misidentifications, adulterants, impurities, range of clinical presentations, lack of diagnostic markers, and alternative diagnoses; an extensive complilation of herbs reported to have caused liver injury including greater celandine).</i></div></div></li></ul></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK548684</span><span class="label">PMID: <a href="/pubmed/31643995" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31643995</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Ceftriaxone/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Celecoxib/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK548684&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK548684/?report=reader">PubReader</a></li><li><a href="/books/NBK548684/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK548684" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK548684" style="display:none" title="Cite this Page"><div class="bk_tt">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.  Celandine. [Updated 2017 Jan 22].<span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK548684/pdf/Bookshelf_NBK548684.pdf">PDF version of this page</a> (116K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Bulk Download</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://ftp.ncbi.nlm.nih.gov/pub/litarch/29/31/" ref="pagearea=source-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Bulk download LiverTox data from FTP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Overviews</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/intro/">Introduction</a></li><li><a href="/books/n/livertox/Causality/">Causality</a></li><li><a href="/books/n/livertox/ClinicalCourse/">Clinical Course</a></li><li><a href="/books/n/livertox/ClinicalOutcome/">Clinical Outcomes</a></li><li><a href="/books/n/livertox/ImmuneFeatures/">Immune Features</a></li><li><a href="/books/n/livertox/DrugCategory/">Likelihood Scale</a></li><li><a href="/books/n/livertox/Phenotypes_intro/">Phenotypes</a></li><li><a href="/books/n/livertox/Severity/">Severity Grading</a></li><li><a href="/books/n/livertox/CaseReport/">Writing a Case Report</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Support Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/">LiverTox Homepage</a></li><li><a href="/books/n/livertox/aboutus/">About LiverTox</a></li><li><a href="/books/n/livertox/editorsandreviewers/">Editors and Review Committee</a></li><li><a href="/books/n/livertox/alert/">Meetings and News</a></li><li><a href="/books/n/livertox/abbreviation/">Abbreviations Used</a></li><li><a href="/books/n/livertox/glossary/">Glossary</a></li><li><a href="/books/n/livertox/resource/">Information Resources</a></li><li><a href="/books/n/livertox/disclaimer/">User/Medical Advice Disclaimer</a></li><li><a href="/books/n/livertox/Contactus/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>OTHER REFERENCE LINKS</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;pubmedfilters=true&amp;term=Greater+Celandine+AND+Human%5BMH%5D+AND+(drug+induced+liver+injury+OR+jaundice/CI+OR+bile+duct+diseases/CI+OR+liver/DE+OR+liver+diseases/CI)+AND+(%221900/1/1%22%5BEDat%5D%3A%222999/12/31%22%5BEDat%5D)" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Recent References on Greater Celandine: from PubMed.gov</a></li><li><a href="https://clinicaltrials.gov/ct2/results?term=Greater+Celandine" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Trials on Greater Celandine: from ClinicalTrials.gov</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4854416" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4854416" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16664249" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Isolation and Partial Characterization of a New Lectin from Seeds of the Greater Celandine (Chelidonium majus).</a><span class="source">[Plant Physiol. 1985]</span><div class="brieflinkpop offscreen_noflow">Isolation and Partial Characterization of a New Lectin from Seeds of the Greater Celandine (Chelidonium majus).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Peumans WJ, De Ley M, Stinissen HM, Broekaert WF. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Plant Physiol. 1985 Jun; 78(2):379-83. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/10535888" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Acute hepatitis induced by greater celandine (Chelidonium majus).</a><span class="source">[Gastroenterology. 1999]</span><div class="brieflinkpop offscreen_noflow">Acute hepatitis induced by greater celandine (Chelidonium majus).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Benninger J, Schneider HT, Schuppan D, Kirchner T, Hahn EG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Gastroenterology. 1999 Nov; 117(5):1234-7. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31643904" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Chinese and other Asian Herbal Medicines</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Chinese and other Asian Herbal Medicines<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12795472" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Acute hepatitis induced by Greater Celandine (Chelidonium majus).</a><span class="source">[Scand J Gastroenterol. 2003]</span><div class="brieflinkpop offscreen_noflow">Acute hepatitis induced by Greater Celandine (Chelidonium majus).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Stickel F, Pöschl G, Seitz HK, Waldherr R, Hahn EG, Schuppan D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Scand J Gastroenterol. 2003 May; 38(5):565-8. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28379595" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hepatotoxicity induced by greater celandine (Chelidonium majus L.): a review of the literature.</a><span class="source">[Eur Rev Med Pharmacol Sci. 2017]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hepatotoxicity induced by greater celandine (Chelidonium majus L.): a review of the literature.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pantano F, Mannocchi G, Marinelli E, Gentili S, Graziano S, Busardò FP, di Luca NM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur Rev Med Pharmacol Sci. 2017 Mar; 21(1 Suppl):46-52. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31643995" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31643995" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=60467b82739e6e7637bd23cb">Celandine - LiverTox</a><div class="ralinkpop offscreen_noflow">Celandine - LiverTox<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2021-03-08T14:31:14-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@9.2&amp;Host=portal105&amp;ncbi_phid=CE8C89D204676ED10000000000FA004B&amp;ncbi_session=CE8C89D20467B811_0250SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK548684%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK548684&amp;ncbi_domain=livertox&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK548684/&amp;ncbi_pagename=Celandine - LiverTox - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C89D20467B811_0250SID /projects/books/PBooks@9.2 portal105 v4.1.r621975 Fri, Dec 18 2020 02:56:50 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>